Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis

Oncotarget

Volumn 7, Issue 10, 2016, Pages 11553-11566

  Wu, Tianyi ^a   Qu, Lingmei ^a   He, Guoqing ^a   Tian, Linli ^a   Li, Liang ^a   Zhou, Han ^a   Jin, Qian ^a   Ren, Jingyuan ^b   Wang, Yu ^a   Wang, Jingting ^a   Kan, Xuan ^a   Liu, Ming ^a   Shen, Jia ^c   Guo, Mian ^a   Sun, Yanan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Cancer Hospital of Jilin Province   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DNMT1; Laryngeal squamous cell cancer; LncRNA H19; MiR 148a 3p

Indexed keywords

DNA METHYLTRANSFERASE 1; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 148A 3P; RNA H19; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE 1; DNMT1 PROTEIN, HUMAN; H19 LONG NON-CODING RNA; MIRN148 MICRORNA, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ACTIVITY; DNA METHYLATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; MALE; MIDDLE AGED; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; SURVIVAL RATE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DISEASE EXACERBATION; GENETIC TRANSFECTION; GENETICS; HEAD AND NECK TUMOR; HEK293 CELL LINE; LARYNX TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; DNA METHYLATION; FEMALE; HEAD AND NECK NEOPLASMS; HEK293 CELLS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED; RNA, LONG NONCODING; SURVIVAL ANALYSIS; TRANSFECTION; UP-REGULATION;

EID: 84962026430     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7270     Document Type: Article

References (43)

1. Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngologic clinics of North America. 2008; 41:673-695, v.
2. Yu Q, Zhang X, Ji C, Yang H, Gao M, Hong S, Hu G. Survival analysis of laryngeal carcinoma without laryngectomy, radiotherapy, or chemotherapy. Eur Arch Otorhinolaryngol. 2012; 269: 2103-2109.
3. Rudolph E, DyckhoffG, Becher H, Dietz A, Ramroth H. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol. 2011; 268: 165-179.
4. Ren J, Zhu D, Liu M, Sun Y, Tian L. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. Eur J Cancer. 2010; 46: 3409-3416.
5. Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M, Xiao H. MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35: 5953-5963.
6. Tian L, Zhang J, Ge J, Xiao H, Lu J, Fu S, Liu M, Sun Y. MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma. Med Oncol. 2014; 31: 785.
7. Wu TY, Zhang TH, Qu LM, Feng JP, Tian LL, Zhang BH, Li DD, Sun YN, Liu M. MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. International journal of clinical and experimental pathology. 2014; 7: 56-63.
8. Zhang T, Liu M, Wang C, Lin C, Sun Y, Jin D. Downregulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer research. 2011; 31: 3859-3863.
9. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome research. 2012; 22: 1775-1789.
10. Pang KC, Frith MC, Mattick JS. Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends in genetics: TIG. 2006; 22: 1-5.
11. Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Frontiers in genetics. 2012; 3: 219.
12. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends in cell biology. 2011; 21: 354-361.
13. Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J, Liu M. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. The American journal of pathology. 2013; 182: 64-70.
14. Zhang R, Luo H, Wang S, Chen W, Chen Z, Wang HW, Chen Y, Yang J, Zhang X, Wu W, Zhang SY, Shen S, Dong Q, et al. MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1. Neuro-oncology. 2014; 16:1510-22. doi: 10.1093/neuonc/nou111.
15. Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. BioEssays. 2010; 32: 473-480.
16. Monnier P, Martinet C, Pontis J, Stancheva I, Ait-Si-Ali S, Dandolo L. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110: 20693-20698.
17. Zhou X, Yin C, Dang Y, Ye F, Zhang G. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Scientific reports. 2015; 5: 11516.
18. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K, Takagi H. Loss of H19 imprinting in esophageal cancer. Cancer research. 1996; 56: 480-482.
19. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer research. 2002; 62: 6442-6446.
20. Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF, Waye MM. The LncRNA H19 promotes epithelial to mesenchymal transition by functioning as MiRNA sponges in colorectal cancer. Oncotarget. 2015; 6:22513-25. doi: 10.18632/oncotarget.4154.
21. Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, Kwok TT. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis. 2010; 31: 350-358.
22. Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T, Adriaenssens E. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. The Journal of biological chemistry. 2005; 280: 29625-29636.
23. Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T, Curgy JJ. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 2002; 23: 1885-1895.
24. Byun HM, Wong HL, Birnstein EA, WolffEM, Liang G, Yang AS. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer research. 2007; 67: 10753-10758.
25. Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer letters. 2013; 333: 213-221.
26. Ariel I, Miao HQ, Ji XR, Schneider T, Roll D, de Groot N, Hochberg A, Ayesh S. Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Molecular pathology. 1998; 51: 21-25.
27. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E. The H19 non-coding RNA is essential for human tumor growth. PloS one. 2007; 2:e845.
28. Yen RW, Vertino PM, Nelkin BD, Yu JJ, el-Deiry W, Cumaraswamy A, Lennon GG, Trask BJ, Celano P, Baylin SB. Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic acids research. 1992; 20: 2287-2291.
29. Wei Q, Yu D, Liu M, Wang M, Zhao M, Jia W, Ma H, Fang J, Xu W, Chen K, Xu Z, Wang J, Tian L, et al. Genomewide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population. Nature genetics. 2014; 46: 1110-1114.
30. Denaro N, Merlano MC, Russi EG, Lo Nigro C. Non coding RNAs in head and neck squamous cell carcinoma (HNSCC):a clinical perspective. Anticancer research. 2014; 34: 6887-6896.
31. Gyparaki MT, Basdra EK, Papavassiliou AG. MicroRNAs as regulatory elements in triple negative breast cancer. Cancer letters. 2014; 354: 1-4.
32. Xue B, He L. An expanding universe of the non-coding genome in cancer biology. Carcinogenesis. 2014; 35: 1209-1216.
33. Huang JL, Zheng L, Hu YW, Wang Q. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis. 2014; 35: 507-514.
34. Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer letters. 2013; 339: 159-166.
35. Sun T, Ye H, Wu CL, Lee GS, KantoffPW. Emerging players in prostate cancer: long non-coding RNAs. American journal of clinical and experimental urology. 2014; 2: 294-299.
36. Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ, Lee HY, Yang L, Mueller M, Zhou XB, Dandolo L, Szendroedi J, Roden M, Flannery C, et al. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic acids research. 2014; 42: 13799-13811.
37. Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, Ai K. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35: 9163-9169.
38. Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, Xu D, Bi HS, Wang F, Sun SH. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 2013; 34: 577-586.
39. Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y, Huang J, Xu M, Yan J, Yu J. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. The FEBS journal. 2014; 281: 3766-3775.
40. Wu CP, Zhou L, Xie M, Du HD, Tian J, Sun S, Li JY. Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia. PloS one. 2013; 8:e65750.
41. Guo M, Jiang Z, Zhang X, Lu D, Ha AD, Sun J, Du W, Wu Z, Hu L, Khadarian K, Shen J, Lin Z. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A. Carcinogenesis. 2014; 35: 1698-1706.
42. Sun Y, Liu M, Yang B, Li B, Lu J. Role of siRNA silencing of MMP-2 gene on invasion and growth of laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2008; 265: 1385-1391.
43. Yang J, Zhu XB, He LX, Gu ZW, Jin MZ, Ji WY. Clinical significance of epigenetic silencing and re-expression of O6-methylguanine-DNA methyltransferase using epigenetic agents in laryngeal carcinoma. Oncology letters. 2015; 9: 35-42.